Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05413746Not ApplicableCompleted

REOXCARE Dressing to Improve Healing in Diabetic Foot Ulcers (DFU)

Role: lead

NCT04289194Phase 1Completed

Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome

Role: lead

NCT03934671Not ApplicableCompleted

Evaluation of the Efficacy of an Antioxidant Dressing in Chronic Wound Healing

Role: collaborator

NCT02917291Phase 1Unknown

Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury

Role: collaborator

All 4 trials loaded